Sevoflurane

This classification denotes an anesthetic agent with the molecular formula C4H3F7O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 38LVP0K73A, chemically known as 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane but generally known as sevoflurane, which bears US NIH Compound Identifier 5206. European Medicines Agency schedules Sevoflurane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10506MIG. The term SEVOFLURANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25, No. 10 1971, List 11). World Health Organization schedules sevoflurane in its Anatomical Therapeutic Chemical (ATC) Classification. SEVOFLURANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sevoflurane under HS 29091990 and SITC 51616. As of Q4 2014, SEVOFLURANE remains the US FDA Preferred Term for this commodity. Sevoflurane bears US NLM identifiers UMLS ID C0074414 and NCI Concept Code C47717. SMILES: FC(F)(F)C(OCF)C(F)(F)F.